FDA approves first gene therapy for rare immune disorder
The US Food and Drug Administration on March 27 approved the first gene therapy for severe Leukocyte Adhesion Deficiency Type 1 (LAD-1), a rare immune disorder, Medscape reported. The approval marks a…
Read More...
Read More...